trapidil has been researched along with Graft Occlusion, Vascular in 1 studies
Trapidil: A coronary vasodilator agent.
Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siegerstetter, V | 1 |
| Huber, M | 1 |
| Ochs, A | 1 |
| Blum, HE | 1 |
| Rössle, M | 1 |
1 trial available for trapidil and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: a randomized study comparing trapidil plus ticlopidine with heparin treatment.
Topics: Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Graft Occlusion, Vascular | 1999 |